The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by Weill Medical College of Cornell University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00226265
First received: September 14, 2005
Last updated: March 31, 2008
Last verified: March 2008

September 14, 2005
March 31, 2008
January 2000
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00226265 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
The Short Form-36: Pre- Versus Post-Surgical Administration in Cardiac Surgery Patients
The Short Form-36: Pre-vs. Post-Surgical Administration in Cardiac Surgery Patients

The purpose of this study is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

The purpose of this study, is to determine whether the SF-36 can be administered reliably to cardiac surgery patients (two to three days) post-surgery, with the patient answering the questions of this survey from a pre-surgical perspective.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Cardiac Surgery Patients at New York Presbyterian Hospital-Weill Cornell Medical College

  • Coronary Artery Bypass Grafting
  • Heart Diseases
  • Heart Valve Diseases
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
200
September 2007
Not Provided

Inclusion Criteria:

  • Cardiac surgery patients who are between the ages of 18 and 100
  • Are English speaking
  • Able to give consent
  • Undergoing cardiac surgery including (but not limited to):

    • Aortic valve replacement (AVR)
    • Mitral valve replacement (MVR)
    • Tricuspid valve replacement (TVR)
    • Coronary artery bypass graft (CABG).

Exclusion Criteria:

  • Non-cardiac surgery patients
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00226265
1203-069
No
Mary E. Charlson, Weill Cornell Medical College
Weill Medical College of Cornell University
Not Provided
Principal Investigator: Mary E Charlson, MD Weill Medical College of Cornell University
Weill Medical College of Cornell University
March 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP